Latest News

The collaboration will integrate Autolomous’ critical manufacturing management systems with Vineti’s Personalized Therapy Management® (PTM) platform. This will enable both parties…

Together, Körber and Vineti will streamline process development, operations, and manufacturing to deliver advanced therapies to patients in need around…

Partnership will streamline process development and manufacturing to deliver therapies to patients in need.

Lykan Bioscience’s world-class manufacturing capabilities, integrated with Vineti’s leading digital enterprise platform for cell and gene therapy supply chains, will…

Vineti’s enterprise technology will enable critical patient-specific Chain of Custody management for Imvax, supporting Imvax’s goal of reaching more patients…

Amy DuRoss, CEO and Co-founder of Vineti, a committed patient advocate, is blazing a trail to orchestrate the supply chain…

These visionary leaders recognized an opportunity to fill an industry need and are successfully leading their companies to new heights.

Ori Biotech, an innovator in cell and gene therapy manufacturing, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply…

Ori Biotech and Vineti are partnering to produce an integrated solution to streamline the manufacture and delivery of cell and gene therapies (CGTs).

Ori provides…

Platform integration will provide therapy developers with full end-to-end visibility, control, and insights into manufacturing and supply chain.

SAN FRANCISCO, May 10, 2021 (GLOBE NEWSWIRE) — Vineti, the developer of the leading digital platform of record for personalized therapeutics, today announced the release…

McKesson Ventures is one of the most active investors in the biopharma software sector with Vineti, Komodo Health, Evidation and M2Gen among its portfolio companies.…